It has been shown that MDM2 oncoprotein ovexpression is frequently observed in hepatocellular carcinoma (HCC),[21] Thus, MDM2's negative regulation on SPOP adds another layer of impact of MDM2 overexpression in HCC. The gene discussed is MDM2; the disease is hepatocellular carcinoma.